Enigma Marketing Research (EMR) is pleased to announce that it has acquired the global rights from Cabinet Alice de Pastors (CAP) for a database which identifies Supplementary Protection Certificates (SPCs) for pharmaceuticals. The pharmaceutical database was first established in 1992 after the entry in force of the EEC Regulation 1769/92 and 1998 Swiss law and is updated on a monthly basis for 31 European countries.
In 2015, EMR acquired, from CAP, the equivalent database for agrochemicals and in 2017 it launched this database as AgSPC.db. EMR has achieved considerable success with a number of top 10 agrochemical companies subscribing to the quarterly updates.
The pharmaceutical database was first established in 1993 after the entry in force of the EEC Regulation 1769/92 (CE 469/2009). It is updated on a monthly basis for 31 European countries. SPCs extend the life of a patent for a maximum time of five years which can be extended to 5.5 years when the SPC relates to a human medicinal product for which data from clinical trials conducted in accordance with an agreed Paediatric Investigation Plan (PIP) have been submitted. SPC applications must be filed and approved on a country-by-country basis. Any company planning to enter the EU market must establish when the patent for the active ingredient, mixture products or other secondary patents expired and whether SPCs were granted and in force” said Dr Nigel Uttley of EMR.
Since 2000, EMR has published 9 reports which have identified and profiled over 200 active ingredients coming off patent. However, it is essential to additionally check if SPCs exist in order to establish “freedom to operate”.
Over the last 27 years EMR has specialised in providing information and consultancy for the Crop Protection industry. The addition of this new database further establishes EMR in the field of IPR for life sciences.
For further details E-mail email@example.com